Arrowhead Research Corp. Company Profile (NASDAQ:ARWR)

About Arrowhead Research Corp.

Arrowhead Research Corp. logoArrowhead Pharmaceuticals, Inc., formerly Arrowhead Research Corporation, is a biopharmaceutical company. The Company is engaged in developing RiboNucleic Acid interference (RNAi) therapeutics. Its products include ARC-520, ARC-521, ARC-AAT, ARC-F12, ARC-HIF2 and ARC-LPA. ARC-520 is designed to treat chronic hepatitis B virus (HBV) infection. ARC-AAT is an unlocked nucleobase analog containing RNAi-based therapeutic for the treatment of liver disease associated with alpha-1 antitrypsin deficiency (AATD). Its Dynamic Polyconjugate platform is an RNAi delivery system that promotes high levels of target gene knockdown. ARC-F12 is an RNAi-based therapeutic designed to reduce the production of factor 12 for providing a prophylactic treatment for hereditary angioedema and thromboembolic diseases. ARC-LPA is an RNAi-based therapeutic designed to reduce production of apolipoprotein A. ARC-HIF2 is an RNAi-based therapeutic designed to reduce the production of hypoxia-inducible factor 2a.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ARWR
  • CUSIP:
Key Metrics:
  • Previous Close: $7.13
  • 50 Day Moving Average: $6.99
  • 200 Day Moving Average: $5.93
  • 52-Week Range: $3.07 - $8.22
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -5.14
  • P/E Growth: -0.73
  • Market Cap: $427.68M
  • Outstanding Shares: 60,750,000
  • Beta: 2.55
Profitability:
  • Net Margins: -48,980.81%
  • Return on Equity: -100.50%
  • Return on Assets: -79.52%
Debt:
  • Debt-to-Equity Ratio: 0.05%
  • Current Ratio: 3.34%
  • Quick Ratio: 3.34%
Additional Links:
Companies Related to Arrowhead Research Corp.:

Analyst Ratings

Consensus Ratings for Arrowhead Research Corp. (NASDAQ:ARWR) (?)
Ratings Breakdown: 1 Hold Rating, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.80)
Consensus Price Target: $9.44 (34.06% upside)

Analysts' Ratings History for Arrowhead Research Corp. (NASDAQ:ARWR)
Show:
DateFirmActionRatingPrice TargetDetails
9/7/2016Chardan CapitalReiterated RatingBuy$10.00View Rating Details
8/19/2016William BlairInitiated CoverageOutperformView Rating Details
8/17/2016Cantor FitzgeraldInitiated CoverageBuy$15.00View Rating Details
8/10/2016Piper Jaffray Cos.Lower Price TargetOverweight$13.00 -> $8.00View Rating Details
5/11/2016Jefferies GroupReiterated RatingHold$4.75View Rating Details
8/5/2015Royal Bank Of CanadaReiterated RatingHold$9.00View Rating Details
1/22/2015Deutsche Bank AGDowngradeBuy -> Hold$7.00View Rating Details
(Data available from 9/29/2014 forward)

Earnings

Earnings History for Arrowhead Research Corp. (NASDAQ:ARWR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
12/12/2016        
8/9/2016Q316($0.37)($0.32)$0.05 million$39.58 millionViewN/AView Earnings Details
5/10/2016Q216($0.37)($0.35)ViewListenView Earnings Details
2/9/2016Q1($0.41)($0.32)ViewN/AView Earnings Details
12/14/2015Q415($0.39)($0.42)ViewListenView Earnings Details
8/4/2015Q315($0.38)($0.27)ViewN/AView Earnings Details
5/11/2015Q214($0.35)($0.33)$110.00 million$43.75 millionViewListenView Earnings Details
2/9/2015Q114($0.34)($0.41)ViewN/AView Earnings Details
11/25/2014Q413($0.24)($0.33)$40.00 millionViewN/AView Earnings Details
8/12/2014Q313($0.22)($0.22)ViewN/AView Earnings Details
5/6/2014($0.20)($0.31)ViewN/AView Earnings Details
2/4/2014Q4($0.18)($0.33)ViewN/AView Earnings Details
12/18/2013Q4($0.23)($0.43)ViewListenView Earnings Details
5/9/2013Q2 2013($0.41)ViewN/AView Earnings Details
2/13/2013Q1 2013($0.33)ViewN/AView Earnings Details
12/20/2012Q4 2012($0.43)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Arrowhead Research Corp. (NASDAQ:ARWR)
Current Year EPS Consensus Estimate: $-1.31 EPS
Next Year EPS Consensus Estimate: $-1.37 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.44)($0.35)($0.39)
Q2 20163($0.42)($0.37)($0.39)
Q3 20162($0.40)($0.38)($0.39)
Q4 20162($0.34)($0.31)($0.33)
Q1 20171($0.33)($0.33)($0.33)
Q2 20171($0.36)($0.36)($0.36)
Q3 20171($0.33)($0.33)($0.33)
Q4 20171($0.36)($0.36)($0.36)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Arrowhead Research Corp. (NASDAQ:ARWR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Arrowhead Research Corp. (NASDAQ:ARWR)
Insider Ownership Percentage: 3.90%
Institutional Ownership Percentage: 33.92%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/23/2016Kenneth Allen MyszkowskiCFOSell6,900$8.00$55,200.00View SEC Filing  
8/22/2016Kenneth Allen MyszkowskiCFOSell13,100$8.00$104,800.00View SEC Filing  
12/30/2015Kenneth Allen MyszkowskiCFOSell23,347$6.13$143,117.11View SEC Filing  
10/28/2015Mauro FerrariDirectorBuy400$7.62$3,048.00View SEC Filing  
10/9/2015Mauro FerrariDirectorBuy1,900$6.19$11,761.00View SEC Filing  
1/5/2015David L LewisInsiderSell15,000$8.01$120,150.00View SEC Filing  
10/15/2014Christopher Richard AnzaloneCEOBuy16,000$6.32$101,120.00View SEC Filing  
10/1/2014Charles MckenneyDirectorSell2,500$14.70$36,750.00View SEC Filing  
9/30/2014David L LewisInsiderSell15,000$15.02$225,300.00View SEC Filing  
9/26/2014Douglas B GivenDirectorSell2,000$15.24$30,480.00View SEC Filing  
6/9/2014Charles MckenneyDirectorSell22,000$14.32$315,040.00View SEC Filing  
2/12/2014Kenneth Allen MyszkowskiCFOSell16,000$18.77$300,320.00View SEC Filing  
2/7/2014Edward W FrykmanDirectorSell3,148$15.98$50,305.04View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Arrowhead Research Corp. (NASDAQ:ARWR)
DateHeadline
biz.yahoo.com logoARROWHEAD PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of (NASDAQ:ARWR)
biz.yahoo.com - September 29 at 8:23 AM
News IconStock Perspective: Arrowhead Research Corporation (NASDAQ:ARWR) Company Earnings Watch - Frisco Fastball (NASDAQ:ARWR)
friscofastball.com - September 14 at 8:49 PM
News IconWhat are Analysts Expecting for Arrowhead Research Corporation ... - Frisco Fastball (NASDAQ:ARWR)
friscofastball.com - September 13 at 3:35 PM
News IconArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) earnings reaction history - The Independent Republic (NASDAQ:ARWR)
theindependentrepublic.com - September 12 at 3:34 PM
News IconIntraday Active Biotech Stocks News: Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR), Peregrine Pharmaceuticals ... - The Voice Registrar (NASDAQ:ARWR)
voiceregistrar.com - September 12 at 3:34 PM
investornewswire.com logoWill Arrowhead Research Corporation (NASDAQ:ARWR) Surprise Analysts? - Investor Newswire (NASDAQ:ARWR)
www.investornewswire.com - September 11 at 8:21 AM
News IconPlacing Arrowhead Research Corporation (NASDAQ:ARWR) Shares Under the Microscope - Post News (NASDAQ:ARWR)
www.kentuckypostnews.com - September 9 at 8:23 AM
News IconChardan Capital Reiterates Buy at Arrowhead Research Corp. (NASDAQ: ARWR) - BNB Daily (blog) (NASDAQ:ARWR)
www.baseball-news-blog.com - September 8 at 10:02 AM
finance.yahoo.com logoArrowhead Pharmaceuticals Initiates Phase 2 Study of ARC-AAT (NASDAQ:ARWR)
finance.yahoo.com - September 6 at 8:23 AM
finance.yahoo.com logo7:31 am Arrowhead initiates a Phase 2 clinical study of ARC-AAT, an investigational RNAi-based medicine for the treatment of liver disease associated with alpha-1 antitrypsin deficiency (NASDAQ:ARWR)
finance.yahoo.com - September 6 at 8:22 AM
finance.yahoo.com logoArrowhead Pharmaceuticals to Present at Upcoming September Conferences (NASDAQ:ARWR)
au.finance.yahoo.com - September 1 at 12:02 PM
News IconKenneth Allen Myszkowski Sells 6900 Shares of Arrowhead Research Corp. (ARWR) Stock (NASDAQ:ARWR)
larampadinapoli.com - August 25 at 8:59 PM
finance.yahoo.com logoArrowhead (ARWR) Exited Third Quarter with a Strong Balance Sheet (NASDAQ:ARWR)
finance.yahoo.com - August 23 at 3:36 PM
News IconCrowd Perspectives & Analyst Views on Arrowhead Research Corporation (NASDAQ:ARWR)? - Post News (NASDAQ:ARWR)
www.kentuckypostnews.com - August 21 at 3:33 PM
capitalcube.com logoETF’s with exposure to Arrowhead Pharmaceuticals, Inc. : August 19, 2016 (NASDAQ:ARWR)
www.capitalcube.com - August 19 at 4:14 PM
finance.yahoo.com logoARROWHEAD PHARMACEUTICALS, INC. Financials (NASDAQ:ARWR)
finance.yahoo.com - August 18 at 3:43 PM
fool.com logoWhat Caused Arrowhead Pharmaceuticals to Skyrocket 12.5% Today (NASDAQ:ARWR)
www.fool.com - August 18 at 3:43 PM
finance.yahoo.com logoCoverage initiated on Arrowhead by Cantor Fitzgerald (NASDAQ:ARWR)
finance.yahoo.com - August 18 at 11:59 AM
capitalcube.com logoArrowhead Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ARWR-US : August 15, 2016 (NASDAQ:ARWR)
www.capitalcube.com - August 15 at 10:49 AM
capitalcube.com logoArrowhead Pharmaceuticals, Inc. :ARWR-US: Earnings Analysis: Q3, 2016 By the Numbers : August 12, 2016 (NASDAQ:ARWR)
www.capitalcube.com - August 12 at 3:47 PM
publicnow.com logoArrowhead Pharmaceuticals Closes $45 Million Private Offering (NASDAQ:ARWR)
www.publicnow.com - August 12 at 12:12 PM
News IconBiotech Company Targeting a $12 Billion Market (NASDAQ:ARWR)
www.ssuchronicle.com - August 11 at 12:49 PM
biz.yahoo.com logoARROWHEAD PHARMACEUTICALS, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Other Events, Financial S (NASDAQ:ARWR)
biz.yahoo.com - August 10 at 10:02 PM
News IconArrowhead Pharmaceuticals plans to raise $45 million (NASDAQ:ARWR)
host.madison.com - August 10 at 9:39 AM
cnbc.com logoArrowhead Research reports 3Q loss (NASDAQ:ARWR)
www.cnbc.com - August 10 at 9:39 AM
finance.yahoo.com logoEdited Transcript of ARWR earnings conference call or presentation 9-Aug-16 8:30pm GMT (NASDAQ:ARWR)
finance.yahoo.com - August 10 at 9:39 AM
finance.yahoo.com logoArrowhead Reports Fiscal 2016 Third Quarter Results (NASDAQ:ARWR)
finance.yahoo.com - August 9 at 4:40 PM
biz.yahoo.com logoARROWHEAD PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statemen (NASDAQ:ARWR)
biz.yahoo.com - August 9 at 4:40 PM
publicnow.com logoArrowhead Pharmaceuticals Prices $45 Million Private Offering (NASDAQ:ARWR)
www.publicnow.com - August 9 at 12:25 PM
capitalcube.com logoETF’s with exposure to Arrowhead Pharmaceuticals, Inc. : August 8, 2016 (NASDAQ:ARWR)
www.capitalcube.com - August 8 at 3:38 PM
capitalcube.com logoArrowhead Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ARWR-US : August 3, 2016 (NASDAQ:ARWR)
www.capitalcube.com - August 3 at 12:12 PM
twst.com logoArrowhead Research Corporation: Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Third Quarter Results (NASDAQ:ARWR)
www.twst.com - August 2 at 9:16 PM
publicnow.com logoArrowhead Pharmaceuticals to Webcast Fiscal 2016 Third Quarter Results (NASDAQ:ARWR)
www.publicnow.com - August 2 at 8:22 AM
ftsenews.co.uk logoArrowhead Research Corporation (NASDAQ:ARWR) Updated Price Targets - FTSE News (NASDAQ:ARWR)
www.ftsenews.co.uk - July 25 at 8:24 AM
News IconEarnings Focus and Crowd Sourced Sentiment Review for Arrowhead Research Corporation (NASDAQ:ARWR) - TGP (NASDAQ:ARWR)
telanaganapress.com - July 22 at 11:47 AM
capitalcube.com logoArrowhead Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ARWR-US : July 22, 2016 (NASDAQ:ARWR)
www.capitalcube.com - July 22 at 8:20 AM
News IconEquity Roundup: Stock Performance Focus on Arrowhead Research Corporation (NASDAQ:ARWR) - Press Telegraph (NASDAQ:ARWR)
presstelegraph.com - July 19 at 3:35 PM
News IconCrowd Rating and Earnings Recap for Arrowhead Research Corporation (NASDAQ:ARWR) - Telanagana Press (NASDAQ:ARWR)
telanaganapress.com - July 16 at 3:34 PM
News IconArrowhead Research Corporation (NASDAQ:ARWR) Wall Street Analyst Recommendation Outlook - Telanagana Press (NASDAQ:ARWR)
telanaganapress.com - July 14 at 12:29 PM
News IconCompany Stock Focus for Arrowhead Research Corporation (NASDAQ:ARWR): Which Way Will Shares Head? - Press Telegraph (NASDAQ:ARWR)
presstelegraph.com - July 12 at 6:58 AM
News IconTrading Performance and Target Watch for Arrowhead Research Corporation (NASDAQ:ARWR) - Press Telegraph (NASDAQ:ARWR)
presstelegraph.com - July 12 at 6:58 AM
capitalcube.com logoArrowhead Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ARWR-US : July 11, 2016 (NASDAQ:ARWR)
www.capitalcube.com - July 11 at 8:40 AM
News IconSentiment Report: Arrowhead Research Corp (NASDAQ:ARWR) - Press Telegraph (NASDAQ:ARWR)
presstelegraph.com - July 7 at 3:37 PM
News IconArrowhead Research Corporation (NASDAQ:ARWR) Stock Update: Check on Ratings and Target Price - Telanagana Press (NASDAQ:ARWR)
telanaganapress.com - July 7 at 11:31 AM
News IconStock Rating Watch and Earnings Insight for Arrowhead Research Corporation (NASDAQ:ARWR) - Press Telegraph (NASDAQ:ARWR)
presstelegraph.com - July 6 at 8:24 AM
publicnow.com logoArrowhead Pharmaceuticals to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference (NASDAQ:ARWR)
www.publicnow.com - July 6 at 8:01 AM
finance.yahoo.com logoArrowhead Pharmaceuticals to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference (NASDAQ:ARWR)
finance.yahoo.com - July 6 at 7:30 AM
News IconCan Arrowhead Research Corporation (NASDAQ:ARWR) Improve on the Earnings Front? - Engelwood Daily (NASDAQ:ARWR)
www.engelwooddaily.com - July 5 at 3:34 PM
investornewswire.com logoCan Arrowhead Research Corporation (NASDAQ:ARWR) Keep Up with Analyst Expectations? - Investor Newswire (NASDAQ:ARWR)
www.investornewswire.com - July 2 at 3:37 PM
capitalcube.com logoETF’s with exposure to Arrowhead Pharmaceuticals, Inc. : July 1, 2016 (NASDAQ:ARWR)
www.capitalcube.com - July 1 at 5:54 PM

Social

Arrowhead Research Corp. (NASDAQ:ARWR) Chart for Thursday, September, 29, 2016


Last Updated on 9/29/2016 by MarketBeat.com Staff